Phathom Pharmaceuticals appoints Sanjeev Narula as CFO and Business Officer effective Oct 6, 2025

Phathom Pharmaceuticals, Inc.

Sanjeev Narula named Chief Financial and Business Officer; replaces Robert Breedlove as principal financial officer.
Initial base salary of $550,000 with annual target bonus of 50% of base salary.
Receives stock options for 200,000 shares (4-year vest) and 144,000 RSUs (3-year annual vest).
Narula previously CFO of Intra-Cellular Therapies and Viatris; brings extensive biopharma finance experience.
Robert Breedlove continues as Vice President, Finance and principal accounting officer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.